Felix Deuss

Structural Immunology researcher, Monash University

[Felix Deuss @FelixDeuss]

Our CD96 story made it to p6 of the Herald Sun @rberrylab @DrGabbyWatson !! Very exciting times. Check out the full publication https://t.co/NE9nQBrLgY

[Felix Deuss @FelixDeuss]

@politicsabc @AndrewBGreene Call me cynical, but I'm waiting for the follow up story about how some current govt minister was a former shareholder in said ship

[Audax Bio @audax_bio]

We are honoured to be recognised as Australian Emerging Company of the Year Award at the prestigious @AusBiotech and @JNJInnovation Industry Excellence Awards

[Felix Deuss @FelixDeuss]

@AneekaSimonis @MelbPressClub Well earned recognition of your hard work in women's safety in Victoria. Congrats!

[Felix Deuss @FelixDeuss]

@Jamie_Rossjohn @ImagingCoE @arc_gov_au As a scientist Kat was an inspiration to me and many other ECRs. I didn't know her personally, but it is clear that she has touched many lives. May she rest in peace

[Felix Deuss @FelixDeuss]

@joshuamhardy @CoulibalyLab @MonashBDI Congratulations Josh!

[Rossjohn lab @RossjohnLab]

We are hiring. An exciting opportunity has become available for a Research fellow. 👇 @ImagingCoE @MonashBDI #structural_immunology #Tcells #proteins #KIR #immunity #infection #rossjohnlab https://t.co/wcXD04Spyb

[Audax Bio @audax_bio]

Are you looking for a new role in a fast-paced environment with a great team? Do you have exceptional organisation, communication and administration skills? We're looking for a Business Support Officer to support the day-to-day operations of oNKo-innate.

https://t.co/L7nkgKZNwH

[Aneeka Simonis @AneekaSimonis]

Anti-lockdown have now taken over Albert Park lake. Can’t see any police yet @theheraldsun

[Audax Bio @audax_bio]

Could you be the in vivo biologist we’re looking for? Applications close this Sunday 23 August 2020, 11:55pm AEST! #sci_jobs #biotech #immunotherapy

[richard berry @richberry1983]

Calling all protein chemists, cell biologists and in vivo specialists. Australia's most exciting biotech start-up, @oNKo_innate has 5 new positions closing next week. Come and work alongside @KitePharma and @GileadSciences to help us cure cancer. See https://t.co/oR6ilSnHrV

[richard berry @richberry1983]

Blown away by the work being done by the oNKO screening team. Come and Help us discover and translate novel and exciting biology right here in Melbourne

[Felix Deuss @FelixDeuss]

@DrRBirkinshaw @theczabs @pseudokinase @BlewittMarnie Awesome stuff! Congratulations rich!

[Audax Bio @audax_bio]

4 more exciting positions open!

Senior Research Officer & Research Officer -Screening Team
https://t.co/NtGX5pHPNb

https://t.co/dLDF7v7Q6b

Research Officer - Protein Engineering
https://t.co/jAV2SmoW37

HEW 5, Research Officer - Cell Therapy
https://t.co/UDd5oMVc9d

[richard berry @richberry1983]

Amazing opportunities are like buses. You wait around for years and then 4 come along at once!!! Come and help us cure cancer at Australia’s most exciting biotech

[Felix Deuss @FelixDeuss]

@Jamie_Rossjohn Go Mai!

[Elisabeth Bik @MicrobiomDigest]

Dear Tweeps, I present to you the Mysterious Case of the Two Papers With Identical Results.

In this thread, we will learn how identical results can obtained in both Gastric Cancer as well as in Lung Cancer.

HT: @nirmalya22 and @SairamJabba

[Felix Deuss @FelixDeuss]

@MoradiShoeib What's relief! Congrats on the new job

[Felix Deuss @FelixDeuss]

@DrRBirkinshaw @WEHI_research @tham_lab @PhillPymm @TheDohertyInst @ProfDaleGodfrey @DrNGPhD @WheatleyAtotheK Nice curves Rich!

[Nicholas Huntington @Dr_Nick_Bikes]

Immunotherapy biotech scores Gilead partnership https://t.co/GQYa45QUBC

[Felix Deuss @FelixDeuss]

@cmdenardo @oNKo_innate I hope to one day be as funny as you!

[Felix Deuss @FelixDeuss]

Stoked for the opportunity to be part of this exciting collaboration! A fantastic result for Aussie biotech. CAR NK cells are the next big thing in cancer treatment. Watch this space! @oNKo_innate

[Audax Bio @audax_bio]

Recent clinical data supports a role for CAR NK cells in cancer treatment. oNKo-Innate, an NK cell biotech company today announce a strategic research collaboration with the leading CAR T cell company @KitePharma to develop novel CAR NK cell products for cancer immunotherapy.